(PDN) Invesco FTSE RAFI Developed - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E7351

Common Stocks, Small Cap, Mid Cap, Developed Markets, Ex US

Description: PDN Invesco FTSE RAFI Developed

The Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF (PDN) is an exchange-traded fund that tracks the performance of small and mid-sized companies in developed markets outside the United States. The fund invests at least 90% of its assets in the securities that comprise its underlying index, which is comprised of approximately 1,500 common stocks.

The index is constructed using a fundamental weighting methodology, which considers four key measures of company size: book value plus intangibles, adjusted cash flow, adjusted sales, and dividend plus buybacks. This approach allows the fund to capture the performance of companies with strong fundamentals, potentially reducing the impact of market volatility.

From a performance perspective, key metrics to evaluate PDN include its tracking error, expense ratio, and dividend yield. A low tracking error indicates that the fund is effectively replicating its underlying index, while a competitive expense ratio is essential for long-term returns. Additionally, the dividend yield can provide insight into the funds income generation potential.

To further assess PDNs investment potential, its essential to examine its sector allocation, geographic distribution, and holdings turnover. A diversified sector allocation and geographic distribution can help mitigate risk, while a low holdings turnover may indicate a more stable investment approach. By analyzing these metrics, investors can gain a deeper understanding of PDNs underlying characteristics and make more informed investment decisions.

Additional Sources for PDN ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

PDN ETF Overview

Market Cap in USD 355m
Category Foreign Small/Mid Value
TER 0.49%
IPO / Inception 2007-09-27

PDN ETF Ratings

Growth Rating 39.4
Fundamental -
Dividend Rating 65.8
Rel. Strength 7
Analysts -
Fair Price Momentum 36.88 USD
Fair Price DCF -

PDN Dividends

Dividend Yield 12m 3.43%
Yield on Cost 5y 5.06%
Annual Growth 5y 11.38%
Payout Consistency 87.6%
Payout Ratio %

PDN Growth Ratios

Growth Correlation 3m 99.2%
Growth Correlation 12m 56.6%
Growth Correlation 5y 25.1%
CAGR 5y 10.16%
CAGR/Max DD 5y 0.30
Sharpe Ratio 12m 1.65
Alpha 10.44
Beta 0.731
Volatility 13.02%
Current Volume 7.9k
Average Volume 20d 12.3k
Stop Loss 37.6 (-3.5%)
What is the price of PDN shares?
As of July 12, 2025, the stock is trading at USD 38.97 with a total of 7,875 shares traded.
Over the past week, the price has changed by +1.02%, over one month by +3.42%, over three months by +19.67% and over the past year by +21.41%.
Is Invesco FTSE RAFI Developed a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Invesco FTSE RAFI Developed (NYSE ARCA:PDN) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.41 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PDN is around 36.88 USD . This means that PDN is currently overvalued and has a potential downside of -5.36%.
Is PDN a buy, sell or hold?
Invesco FTSE RAFI Developed has no consensus analysts rating.
What are the forecasts for PDN share price target?
According to our own proprietary Forecast Model, PDN Invesco FTSE RAFI Developed will be worth about 42.3 in July 2026. The stock is currently trading at 38.97. This means that the stock has a potential upside of +8.6%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 42.3 8.6%